光子计数探测器CT联合量子迭代重建:对肝脏病灶检出及辐射剂量降低的影响
本研究采用含5–10 mm低/高衰减肝病灶的体模,比较光子计数探测器CT(PCD-CT)联合量子迭代重建(QIR)与能量积分探测器CT(EID-CT)在检出肝脏病灶时的图像噪声、诊断准确性和辐射剂量降低潜力。结果显示QIR级别越高噪声越低,PCD-CT联合QIR-4在低剂量下病灶检出AUC显著高于EID-CT,并具备大幅降低辐射剂量的潜力。
要点
- QIR-4在1.25 mGy时较EID-CT VMI噪声降低59%,病灶检出AUC更高。
- 低剂量下PCD-CT联合QIR-4对高/低衰减病灶检出AUC达0.917/0.900。
- PCD-CT联合QIR-4相比EID-CT VMI潜在降低辐射剂量54%。
关键影像表现/征象
- 图像噪声随QIR级别增加而降低,QIR-4在5、2.5、1.25 mGy时较EID-CT VMI噪声分别降低41%、45%、59%。
- QIR-4较EID-CT LBI噪声分别降低12%、18%、33%(对应5、2.5、1.25 mGy)。
- 较高QIR级别下峰值空间频率稍向低频移动。
- PCD-CT病灶检出准确性高于EID-CT VMI,且在最低剂量时提升最明显。
诊断标准与关键数值
- 在1.25 mGy下,高衰减病灶检出AUC:QIR-4为0.917,EID-CT VMI为0.677。
- 在1.25 mGy下,低衰减病灶检出AUC:QIR-4为0.900,EID-CT VMI为0.726。
- 在1.25 mGy下,QIR-4的AUC为0.900,EID-CT LBI为0.854。
- PCD-CT联合QIR-4的辐射剂量降低潜力:5 mGy时较VMI降低54%,2.5 mGy时较LBI降低39%。
临床应用与阅片要点
- 在低剂量腹部CT中,可优先考虑PCD-CT联合高等级QIR(如QIR-4)以维持或提升小肝病灶检出。
- QIR级别增高时噪声降低但空间频率稍向低频移动,需注意图像纹理变化对病灶边缘判断的影响。
- 对于高/低衰减肝病灶,PCD-CT在低剂量下的检出优势更明显,可支持降低辐射剂量的扫描方案。
局限性
- 研究为体模实验,非临床患者数据,结果需临床验证。
- 病灶仅模拟5–10 mm低/高衰减类型,未涵盖其他病理类型。
- 仅评估了特定扫描仪和重建参数,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess image noise, diagnostic performance, and potential for radiation dose reduction of photon-counting detector (PCD) computed tomography (CT) with quantum iterative reconstruction (QIR) in the detection of hypoattenuating and hyperattenuating focal liver lesions compared with energy-integrating detector (EID) CT.
MATERIALS AND METHODS: A medium-sized anthropomorphic abdominal phantom with liver parenchyma and lesions (diameter, 5-10 mm; hypoattenuating and hyperattenuating from -30 HU to +90 HU at 120 kVp) was used. The phantom was imaged on ( a ) a third-generation dual-source EID-CT (SOMATOM Force, Siemens Healthineers) in the dual-energy mode at 100 and 150 kVp with tin filtration and ( b ) a clinical dual-source PCD-CT at 120 kVp (NAEOTOM Alpha, Siemens). Scans were repeated 10 times for each of 3 different radiation doses of 5, 2.5, and 1.25 mGy. Datasets were reconstructed as virtual monoenergetic images (VMIs) at 60 keV for both scanners and as linear-blended images (LBIs) for EID-CT. For PCD-CT, VMIs were reconstructed with different strength levels of QIR (QIR 1-4) and without QIR (QIR-off). For EID-CT, VMIs and LBIs were reconstructed using advanced modeled iterative reconstruction at a strength level of 3. Noise power spectrum was measured to compare image noise magnitude and texture. A channelized Hotelling model observer was used to assess diagnostic accuracy for lesion detection. The potential for radiation dose reduction using PCD-CT was estimated for the QIR strength level with the highest area under the curve compared with EID-CT for each radiation dose.
RESULTS: Image noise decreased with increasing QIR level at all radiation doses. Using QIR-4, noise reduction was 41%, 45%, and 59% compared with EID-CT VMIs and 12%, 18%, and 33% compared with EID-CT LBIs at 5, 2.5, and 1.25 mGy, respectively. The peak spatial frequency shifted slightly to lower frequencies at higher QIR levels. Lesion detection accuracy increased at higher QIR levels and was higher for PCD-CT compared with EID-CT VMIs. The improvement in detection with PCD-CT was strongest at the lowest radiation dose, with an area under the receiver operating curve of 0.917 for QIR-4 versus 0.677 for EID-CT VMIs for hyperattenuating lesions, and 0.900 for QIR-4 versus 0.726 for EID-CT VMIs for hypoattenuating lesions. Compared with EID-CT LBIs, detection was higher for QIR 1-4 at 2.5 mGy and for QIR 2-4 at 1.25 mGy (eg, 0.900 for QIR-4 compared with 0.854 for EID-CT LBIs at 1.25 mGy). Radiation dose reduction potential of PCD-CT with QIR-4 was 54% at 5 mGy compared with VMIs and 39% at 2.5 mGy compared with LBIs.
CONCLUSIONS: Compared with EID-CT, PCD-CT with QIR substantially improved focal liver lesion detection, especially at low radiation dose. This enables substantial radiation dose reduction while maintaining diagnostic accuracy.
引用
- Racine, Mergen, Viry, et al. Photon-Counting Detector CT With Quantum Iterative Reconstruction: Impact on Liver Lesion Detection and Radiation Dose Reduction. Invest Radiol. 2022. PMID: 36094810. doi:10.1097/RLI.0000000000000925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。